Log in

Allena Pharmaceuticals News Headlines (NASDAQ:ALNA)

$1.89
+0.02 (+1.07 %)
(As of 11/21/2019 01:21 AM ET)
Today's Range
$1.81
Now: $1.89
$1.93
50-Day Range
$1.62
MA: $4.09
$5.91
52-Week Range
$1.55
Now: $1.89
$10.66
Volume181,400 shs
Average Volume149,319 shs
Market Capitalization$44.35 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Headlines

Allena Pharmaceuticals (NASDAQ ALNA) News Headlines

Source:
DateHeadline
Do Directors Own Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares?Do Directors Own Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares?
finance.yahoo.com - November 18 at 7:22 AM
FY2019 Earnings Forecast for Allena Pharmaceuticals Inc (NASDAQ:ALNA) Issued By Jefferies Financial GroupFY2019 Earnings Forecast for Allena Pharmaceuticals Inc (NASDAQ:ALNA) Issued By Jefferies Financial Group
www.americanbankingnews.com - November 18 at 2:48 AM
FY2019 Earnings Forecast for Allena Pharmaceuticals Inc (NASDAQ:ALNA) Issued By WedbushFY2019 Earnings Forecast for Allena Pharmaceuticals Inc (NASDAQ:ALNA) Issued By Wedbush
www.americanbankingnews.com - November 18 at 2:48 AM
Allena Pharmaceuticals Inc (NASDAQ:ALNA) Short Interest UpdateAllena Pharmaceuticals Inc (NASDAQ:ALNA) Short Interest Update
www.americanbankingnews.com - November 16 at 4:24 AM
Zacks: Brokerages Anticipate Allena Pharmaceuticals Inc (NASDAQ:ALNA) Will Announce Earnings of -$0.46 Per ShareZacks: Brokerages Anticipate Allena Pharmaceuticals Inc (NASDAQ:ALNA) Will Announce Earnings of -$0.46 Per Share
www.americanbankingnews.com - November 14 at 11:36 PM
Allena Pharmaceuticals (ALNA) Buy Rating Reaffirmed at CowenAllena Pharmaceuticals' (ALNA) Buy Rating Reaffirmed at Cowen
www.americanbankingnews.com - November 14 at 8:49 PM
Allena Pharmaceuticals (NASDAQ:ALNA) Issues  Earnings ResultsAllena Pharmaceuticals (NASDAQ:ALNA) Issues Earnings Results
www.americanbankingnews.com - November 14 at 4:36 PM
Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business UpdateAllena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 13 at 12:06 PM
Allena Demolished: Weak Phase III And Dismal PrognosisAllena Demolished: Weak Phase III And Dismal Prognosis
seekingalpha.com - November 12 at 10:19 AM
Allena Pharmaceuticals (ALNA) Presents URIROX-1 and Study 206 Topline Results - SlideshowAllena Pharmaceuticals (ALNA) Presents URIROX-1 and Study 206 Topline Results - Slideshow
seekingalpha.com - November 8 at 6:39 PM
Credit Suisse Group Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to NeutralCredit Suisse Group Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to Neutral
www.americanbankingnews.com - November 8 at 11:23 AM
Allena Pharma down 47% on "positive" reloxaliase dataAllena Pharma down 47% on "positive" reloxaliase data
seekingalpha.com - November 7 at 1:25 PM
Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206
finance.yahoo.com - November 7 at 7:48 AM
Allena Pharmaceuticals Inc (NASDAQ:ALNA) Receives Average Rating of "Buy" from AnalystsAllena Pharmaceuticals Inc (NASDAQ:ALNA) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - November 1 at 11:03 PM
Allena Pharmaceuticals Inc (NASDAQ:ALNA) Short Interest Up 5.3% in OctoberAllena Pharmaceuticals Inc (NASDAQ:ALNA) Short Interest Up 5.3% in October
www.americanbankingnews.com - November 1 at 1:19 AM
Assessing Allena PharmaceuticalsAssessing Allena Pharmaceuticals
seekingalpha.com - October 23 at 6:34 PM
Allena Pharmaceuticals to Present New Data on Reloxaliase and ALLN-346 Development Programs at Upcoming ASN Kidney Week and ACR/ARP Annual MeetingAllena Pharmaceuticals to Present New Data on Reloxaliase and ALLN-346 Development Programs at Upcoming ASN Kidney Week and ACR/ARP Annual Meeting
finance.yahoo.com - October 17 at 8:28 AM
Allena Pharmaceuticals, Inc. (ALNA) Upgraded to Buy: Here's WhyAllena Pharmaceuticals, Inc. (ALNA) Upgraded to Buy: Here's Why
finance.yahoo.com - October 8 at 12:45 PM
ALNA Allena Pharmaceuticals, Inc. Common StockALNA Allena Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - October 7 at 8:29 PM
Allena Pharma completes enrollment in late-stage study of reloxaliase in fat malabsorption disorderAllena Pharma completes enrollment in late-stage study of reloxaliase in fat malabsorption disorder
seekingalpha.com - September 17 at 6:26 AM
Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric HyperoxaluriaAllena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria
finance.yahoo.com - September 17 at 6:26 AM
Allena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for ReloxaliaseAllena Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Enteric Hyperoxaluria and Potential for Reloxaliase
finance.yahoo.com - September 11 at 9:03 AM
Allena Pharmaceuticals: Unique Treatment For Enteric Hyperoxaluria Not Reflected In ValuationAllena Pharmaceuticals: Unique Treatment For Enteric Hyperoxaluria Not Reflected In Valuation
seekingalpha.com - September 7 at 6:13 AM
Allena Pharmaceuticals to Participate in Upcoming Investor Conferences in SeptemberAllena Pharmaceuticals to Participate in Upcoming Investor Conferences in September
finance.yahoo.com - August 29 at 11:13 AM
Allena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business UpdateAllena Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 7 at 9:11 AM
Allena Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare ConferenceAllena Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 8:36 AM
Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings?Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings?
finance.yahoo.com - July 31 at 6:56 PM
AmerisourceBergen (ABC) Q3 Earnings: What's in the Offing?AmerisourceBergen (ABC) Q3 Earnings: What's in the Offing?
finance.yahoo.com - July 26 at 7:21 PM
Masimo (MASI) to Report Q2 Earnings: What's in the Offing?Masimo (MASI) to Report Q2 Earnings: What's in the Offing?
finance.yahoo.com - July 26 at 10:31 AM
Will Flagship Impella Drive ABIOMED's (ABMD) Q1 Earnings?Will Flagship Impella Drive ABIOMED's (ABMD) Q1 Earnings?
finance.yahoo.com - July 26 at 10:31 AM
Allena: Kidney Contender With Dialysis In The NewsAllena: Kidney Contender With Dialysis In The News
seekingalpha.com - July 25 at 9:31 AM
Allena Pharma secures $10M capital raiseAllena Pharma secures $10M capital raise
seekingalpha.com - June 28 at 9:22 AM
Allena Pharmaceuticals Showcases Reloxaliase and Enteric Hyperoxaluria Program at OHF International Hyperoxaluria WorkshopAllena Pharmaceuticals Showcases Reloxaliase and Enteric Hyperoxaluria Program at OHF International Hyperoxaluria Workshop
finance.yahoo.com - June 21 at 11:45 AM
Allena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate DisordersAllena Pharmaceuticals Announces Interim Results from Study 206 of Reloxaliase in High Risk Patients with Advanced Oxalate Disorders
finance.yahoo.com - June 4 at 9:28 AM
Allena Pharmaceuticals to Present at Jefferies 2019 Healthcare ConferenceAllena Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 30 at 9:24 AM
All You Need to Know About Allena Pharmaceuticals, Inc. (ALNA) Rating Upgrade to BuyAll You Need to Know About Allena Pharmaceuticals, Inc. (ALNA) Rating Upgrade to Buy
finance.yahoo.com - May 8 at 6:47 PM
Allena Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business UpdateAllena Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 8 at 9:20 AM
Investors Who Bought Allena Pharmaceuticals (NASDAQ:ALNA) Shares A Year Ago Are Now Down 52%Investors Who Bought Allena Pharmaceuticals (NASDAQ:ALNA) Shares A Year Ago Are Now Down 52%
finance.yahoo.com - April 18 at 9:26 AM
Allena Pharmaceuticals Appoints Allene Diaz to its Board of DirectorsAllena Pharmaceuticals Appoints Allene Diaz to its Board of Directors
finance.yahoo.com - April 17 at 9:37 AM
Allena Pharmaceuticals: Red Flags Abound, And That Makes This A Difficult CallAllena Pharmaceuticals: Red Flags Abound, And That Makes This A Difficult Call
seekingalpha.com - April 6 at 9:19 AM
Allena Pharmaceuticals Announces Agreement with Duke Clinical Research Institute for URIROX-2 Pivotal Phase 3 TrialAllena Pharmaceuticals Announces Agreement with Duke Clinical Research Institute for URIROX-2 Pivotal Phase 3 Trial
finance.yahoo.com - March 27 at 9:43 AM
Allena Pharmaceuticals IncAllena Pharmaceuticals Inc
www.bloomberg.com - March 18 at 6:45 PM
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdateAllena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
finance.yahoo.com - March 7 at 9:51 AM
Allena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care ConferenceAllena Pharmaceuticals, Inc. to Present at 39th Annual Cowen & Co. Health Care Conference
finance.yahoo.com - March 5 at 9:48 AM
Allena Greatly Improves Phase III Design Endpoint Support, Improving SentimentAllena Greatly Improves Phase III Design Endpoint Support, Improving Sentiment
seekingalpha.com - February 4 at 5:41 PM
Allena Pharmaceuticals appoints Louis Brenner as CEOAllena Pharmaceuticals appoints Louis Brenner as CEO
seekingalpha.com - January 4 at 10:17 AM
Allena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019Allena Pharmaceuticals Announces Appointment of Louis Brenner, M.D. as Chief Executive Officer and Confirms Key Milestones for 2019
finance.yahoo.com - January 4 at 10:17 AM
Allena Pharmaceuticals aligns with FDA on phase 3 program and accelerated approval pathway for reloxaliase in enteric hyperoxaluriaAllena Pharmaceuticals aligns with FDA on phase 3 program and accelerated approval pathway for reloxaliase in enteric hyperoxaluria
seekingalpha.com - January 2 at 4:49 PM
Allena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric HyperoxaluriaAllena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria
finance.yahoo.com - January 2 at 9:13 AM
Do Hedge Funds Love Allena Pharmaceuticals, Inc. (ALNA)?Do Hedge Funds Love Allena Pharmaceuticals, Inc. (ALNA)?
finance.yahoo.com - December 24 at 9:07 AM
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel